Literature DB >> 11777222

Can we use vertical bore magnetic resonance scanners for murine cardiovascular phenotype characterization? Influence of upright body position on left ventricular hemodynamics in mice.

F Wiesmann1, S Neubauer, A Haase, L Hein.   

Abstract

High resolution magnetic resonance (MR) imaging is uniquely suited for cardiovascular phenotype characterization in transgenic mice. Experimental MR scanners with the high magnetic field strength are commonly built with a vertical bore design. The hemodynamic consequences of a prolonged upright body position in anesthetized mice are, however, unknown. Thus, the purpose of this work was to investigate the influence of a vertical body position on murine systemic blood pressure and left ventricular (LV) hemodynamics over time. We studied six C57Bl/6 mice at 14-16 weeks of age (body weight, 24-28 g) under isoflurane anesthesia. Positioned supine on a 37 degrees C warming pad, a microtip catheter was advanced via the right carotid artery into the left ventricle. Continuous registration of LV hemodynamics was performed at rest and after tilting of the table to a 90-degree vertical position. After tilting, there was a transient decrease of LV systolic pressure to 96% of initial values immediately after tilting with return to baseline level within 6 min. Tilting to vertical position had no influence on LV end-diastolic pressure, heart rate, maximal rate of left ventricular pressure increase, and maximal rate of left ventricular pressure decrease. Over a follow-up period of 60 min in vertical position, there were no significant changes in murine hemodynamics. An acute change of body position is fully compensated by a normal orthostatic response in anesthetized mice. Prolonged upright body position exerts no significant changes in murine LV hemodynamics. Hence, high resolution MR studies for cardiovascular phenotype characterization in transgenic mice performed on vertical bore MR scanners allow measurements under physiologic conditions.

Entities:  

Mesh:

Year:  2001        PMID: 11777222     DOI: 10.1081/jcmr-100108584

Source DB:  PubMed          Journal:  J Cardiovasc Magn Reson        ISSN: 1097-6647            Impact factor:   5.364


  7 in total

1.  Lung perfusion imaging in small animals using 4D micro-CT at heartbeat temporal resolution.

Authors:  Cristian T Badea; Samuel M Johnston; Ergys Subashi; Yi Qi; Laurence W Hedlund; G Allan Johnson
Journal:  Med Phys       Date:  2010-01       Impact factor: 4.071

Review 2.  Current status of cardiac MRI in small animals.

Authors:  J-P Vallée; M K Ivancevic; D Nguyen; D R Morel; M Jaconi
Journal:  MAGMA       Date:  2004-12-16       Impact factor: 2.310

3.  Tomographic digital subtraction angiography for lung perfusion estimation in rodents.

Authors:  Cristian T Badea; Laurence W Hedlund; Ming De Lin; Julie S Boslego Mackel; Ehsan Samei; G Allan Johnson
Journal:  Med Phys       Date:  2007-05       Impact factor: 4.071

4.  Early impairment of transmural principal strains in the left ventricular wall after short-term, high-fat feeding of mice predisposed to cardiac steatosis.

Authors:  Janusz H Hankiewicz; Natasha H Banke; Mariam Farjah; E Douglas Lewandowski
Journal:  Circ Cardiovasc Imaging       Date:  2010-09-13       Impact factor: 7.792

5.  Cardiac micro-computed tomography for morphological and functional phenotyping of muscle LIM protein null mice.

Authors:  Cristian T Badea; Laurence W Hedlund; Julie F Boslego Mackel; Lan Mao; Howard A Rockman; G Allan Johnson
Journal:  Mol Imaging       Date:  2007 Jul-Aug       Impact factor: 4.488

6.  Echo-planar BOLD fMRI of mice on a narrow-bore 9.4 T magnet.

Authors:  Govind Nair; Timothy Q Duong
Journal:  Magn Reson Med       Date:  2004-08       Impact factor: 4.668

7.  Long-term stability of cardiac function in normal and chronically failing mouse hearts in a vertical-bore MR system.

Authors:  Jürgen E Schneider; Karen J Hulbert; Craig A Lygate; Michiel Ten Hove; Paul J Cassidy; Kieran Clarke; Stefan Neubauer
Journal:  MAGMA       Date:  2004-11-08       Impact factor: 2.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.